PetMed Express Board Restructures After Director Resignation
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Petmed Express ( (PETS) ) has provided an announcement.
On July 24, 2025, Diana Garvis Purcel resigned from the board of directors of PetMed Express, Inc., including her roles as Chair of the Audit Committee and a member of the Audit and Compensation and Human Capital Committees. Her resignation was not due to any disagreements with the company. Following her departure, Leslie C.G. Campbell was appointed to serve on the Audit Committee and as its Chair. The board also decided to reduce its size from seven to six directors.
The most recent analyst rating on (PETS) stock is a Sell with a $3.50 price target. To see the full list of analyst forecasts on Petmed Express stock, see the PETS Stock Forecast page.
Spark’s Take on PETS Stock
According to Spark, TipRanks’ AI Analyst, PETS is a Neutral.
Petmed Express shows a mixed financial performance with strong balance sheet stability but weak profitability and inconsistent cash flow. Technical analysis indicates a bearish trend with oversold conditions, while valuation metrics suggest the stock may be overvalued. The earnings call highlights progress in profitability and strategic investments, but challenges remain in sales and competitive pressures. Overall, the stock score reflects these combined factors, indicating moderate potential with significant risks.
To see Spark’s full report on PETS stock, click here.
More about Petmed Express
Average Trading Volume: 133,812
Technical Sentiment Signal: Strong Sell
Current Market Cap: $77.87M
For an in-depth examination of PETS stock, go to TipRanks’ Overview page.
